Mitsuhiro Fujishiro Selected Research

Pepsinogen A (Pepsinogen)

5/2014	Helicobacter pylori infection is positively associated with gallstones: a large-scale cross-sectional study in Japan.
3/2014	Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
1/2014	Associated factors of atrophic gastritis diagnosed by double-contrast upper gastrointestinal barium X-ray radiography: a cross-sectional study analyzing 6,901 healthy subjects in Japan.
1/2013	Background factors of reflux esophagitis and non-erosive reflux disease: a cross-sectional study of 10,837 subjects in Japan.
1/2013	No association of coffee consumption with gastric ulcer, duodenal ulcer, reflux esophagitis, and non-erosive reflux disease: a cross-sectional study of 8,013 healthy subjects in Japan.
12/2012	Development of gastric cancer in nonatrophic stomach with highly active inflammation identified by serum levels of pepsinogen and Helicobacter pylori antibody together with endoscopic rugal hyperplastic gastritis.
4/2011	Assessment of gastroesophageal reflux disease by serodiagnosis of Helicobacter pylori-related chronic gastritis stage.
3/2010	Preventive effects of etodolac, a selective cyclooxygenase-2 inhibitor, on cancer development in extensive metaplastic gastritis, a Helicobacter pylori-negative precancerous lesion.
12/2009	Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels.
4/2009	Long-term results of gastric cancer screening using the serum pepsinogen test method among an asymptomatic middle-aged Japanese population.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mitsuhiro Fujishiro Research Topics

Disease

57	Neoplasms (Cancer) 09/2022 - 01/2002
39	Hemorrhage 07/2022 - 02/2006
23	Stomach Neoplasms (Stomach Cancer) 04/2022 - 02/2004
17	Hepatocellular Carcinoma (Hepatoma) 04/2022 - 07/2005
17	Ulcer 02/2022 - 10/2006
10	Infections 01/2022 - 01/2013
9	Pathologic Constriction (Stenosis) 05/2022 - 02/2010
8	Inflammation (Inflammations) 04/2022 - 01/2002
8	Gastritis 02/2022 - 03/2010
8	Peptic Ulcer (Peptic Ulcers) 01/2018 - 10/2006
7	Fibrosis (Cirrhosis) 04/2022 - 05/2009
7	Atrophy 03/2022 - 04/2008
7	Carcinogenesis 01/2022 - 06/2009
6	Metaplasia 02/2022 - 11/2007
6	Peptic Esophagitis (Reflux Esophagitis) 01/2022 - 04/2011
6	Thromboembolism 10/2021 - 02/2009
6	Crohn Disease (Crohn's Disease) 07/2021 - 10/2019
5	Pancreatic Neoplasms (Pancreatic Cancer) 09/2022 - 06/2011
5	Non-alcoholic Fatty Liver Disease 04/2022 - 01/2020
5	Adenoma (Adenomas) 02/2019 - 06/2009
5	Atrophic Gastritis 07/2016 - 10/2006
4	Esophageal Neoplasms (Esophageal Cancer) 05/2022 - 06/2011
4	Esophageal Stenosis (Esophageal Stricture) 05/2022 - 06/2010
4	Adenocarcinoma 01/2022 - 05/2013
4	Liver Cirrhosis (Hepatic Cirrhosis) 10/2021 - 01/2020
4	Body Weight (Weight, Body) 01/2020 - 03/2012
4	Gastroesophageal Reflux (GERD) 09/2018 - 04/2011
3	Colorectal Neoplasms (Colorectal Cancer) 11/2022 - 06/2009
3	Liver Diseases (Liver Disease) 01/2022 - 01/2020
3	Hepatitis C 01/2022 - 01/2021
3	Neoplasm Metastasis (Metastasis) 10/2021 - 05/2009
3	Lymphatic Metastasis 06/2020 - 05/2013
3	Wounds and Injuries (Trauma) 01/2018 - 01/2014
3	Cardiovascular Diseases (Cardiovascular Disease) 09/2016 - 11/2011
3	Stomach Ulcer (Gastric Ulcer) 01/2013 - 03/2004
2	Syncope (Fainting) 09/2022 - 03/2022
2	Sarcopenia 04/2022 - 01/2022
2	Dysbiosis 03/2022 - 01/2017
2	Disease Progression 02/2022 - 10/2021
2	Ulcerative Colitis 02/2022 - 12/2020
2	Hiatal Hernia 01/2022 - 09/2012
2	Hepatitis B 01/2022 - 01/2021
2	Hemophilia A (Haemophilia) 01/2022 - 01/2021
2	Chronic Hepatitis C 12/2021 - 09/2007
2	Diarrhea 11/2021 - 02/2020
2	Alcoholic Fatty Liver 11/2021 - 01/2021
2	Varicose Veins (Varicose Vein) 10/2021 - 01/2016

Drug/Important Bio-Agent (IBA)

13	Pepsinogen A (Pepsinogen)IBA 05/2014 - 10/2006
12	Pharmaceutical PreparationsIBA 05/2022 - 11/2011
12	Proton Pump InhibitorsIBA 01/2022 - 07/2010
11	Capsules (Microcapsules)IBA 01/2022 - 01/2018
9	AnticoagulantsIBA 09/2022 - 02/2009
9	Fibrinolytic Agents (Antithrombotic Agents)IBA 07/2022 - 07/2012
8	Warfarin (Coumadin)FDA LinkGeneric 11/2021 - 05/2014
8	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2021 - 05/2014
8	AcidsIBA 04/2019 - 04/2011
6	Immune Checkpoint InhibitorsIBA 02/2022 - 06/2020
6	Sorafenib (BAY 43-9006)FDA Link 06/2020 - 09/2019
6	Fibrin Tissue Adhesive (Fibrin Sealant)IBA 01/2019 - 01/2014
5	Indicators and Reagents (Reagents)IBA 09/2022 - 05/2013
5	thienopyridineIBA 10/2021 - 07/2015
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2009
5	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2018 - 05/2012
5	Polyglycolic Acid (Polyglycolide)IBA 01/2016 - 01/2014
4	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2020
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2010
4	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2021 - 02/2009
4	Prostaglandins AIBA 01/2019 - 01/2014
4	Rabeprazole (Aciphex)FDA Link 07/2018 - 03/2012
4	BariumIBA 07/2016 - 12/2011
3	SteroidsIBA 05/2022 - 01/2015
3	Biological ProductsIBA 01/2022 - 05/2009
3	Pemetrexed (MTA)FDA Link 08/2021 - 03/2021
3	RNA (Ribonucleic Acid)IBA 05/2021 - 09/2007
3	Ustekinumab (CNTO 1275)FDA Link 02/2021 - 10/2019
3	lenvatinibIBA 04/2020 - 03/2020
3	Hyaluronic Acid (Hyaluronan)IBA 01/2020 - 02/2006
2	NitrogenIBA 09/2022 - 03/2022
2	Urea (Carbamide)FDA LinkGeneric 09/2022 - 03/2022
2	Dihydrotachysterol (AT 10)IBA 04/2022 - 07/2018
2	Choline (Choline Chloride)IBA 04/2022 - 11/2021
2	tamibaroteneIBA 02/2022 - 01/2022
2	Amino Acids FDA Link 01/2022 - 01/2021
2	AntibodiesIBA 11/2021 - 08/2008

Therapy/Procedure

31	Therapeutics 03/2022 - 01/2003
8	Endoscopic Hemostasis 07/2016 - 03/2004
6	Gastrectomy 05/2012 - 01/2002
5	Surgical Instruments (Clip) 10/2012 - 03/2004
4	Drug Therapy (Chemotherapy) 06/2022 - 01/2012
4	Aftercare (After-Treatment) 10/2021 - 10/2018
4	Ligation 10/2021 - 11/2012
3	Renal Dialysis (Hemodialysis) 10/2021 - 01/2010
3	Endoscopes 02/2021 - 01/2020
3	Liver Transplantation 01/2021 - 07/2020
3	Lymph Node Excision (Lymph Node Dissection) 01/2016 - 04/2008
2	Stents 12/2022 - 07/2012
2	Chemoprevention 11/2022 - 03/2010
2	Sutures (Suture) 02/2022 - 01/2014
2	Molecular Targeted Therapy 01/2022 - 08/2021
2	Length of Stay 01/2022 - 06/2021